Schreiber; Rudy
Patent Applications and Registrations
Patent applications and USPTO patent grants for Schreiber; Rudy.The latest application filed is for "heteroaryl carboxamides".
- Schreiber; Rudy - Menlo Park CA
- SCHREIBER; Rudy - Watertown MA
- Schreiber; Rudy - Mountain View CA
- Schreiber; Rudy - Koln DE
| Patent | Date |
|---|---|
| Heteroaryl carboxamides Grant 10,487,079 - Hendrix , et al. Nov | 2019-11-26 |
| Heteroaryl Carboxamides App 20190040057 - HENDRIX; Martin ; et al. | 2019-02-07 |
| Heteroaryl carboxamides Grant 9,926,311 - Hendrix , et al. March 27, 2 | 2018-03-27 |
| Phenyl Substituted Cycloalkylamines As Monoamine Reputake Inhibitors App 20170204050 - SHAO; Liming ; et al. | 2017-07-20 |
| Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors Grant 9,586,888 - Shao , et al. March 7, 2 | 2017-03-07 |
| Heteroaryl Carboxamides App 20160214975 - Hendrix; Martin ; et al. | 2016-07-28 |
| Heteroaryl carboxamides Grant 9,139,579 - Hendrix , et al. September 22, 2 | 2015-09-22 |
| Phenyl Substituted Cycloalkylamines As Monoamine Reuptake Inhibitors App 20140121282 - SHAO; Liming ; et al. | 2014-05-01 |
| Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors Grant 8,669,291 - Shao , et al. March 11, 2 | 2014-03-11 |
| Heteroaryl Carboxamides App 20130144062 - Hendrix; Martin ; et al. | 2013-06-06 |
| Heteroaryl carboxamides Grant 8,227,598 - Hendrix , et al. July 24, 2 | 2012-07-24 |
| Morphine-bridged Indazole Derivatives App 20090023717 - Feurer; Achim ; et al. | 2009-01-22 |
| Phenyl Substituted Cycloalkylamines As Monoamine Reuptake Inhibitors App 20090005456 - Shao; Liming ; et al. | 2009-01-01 |
| Morpoline-bridged indazole derivatives Grant 7,427,617 - Feurer , et al. September 23, 2 | 2008-09-23 |
| 4-amino-substituted pyrimidine derivatives Grant 7,410,973 - Feurer , et al. August 12, 2 | 2008-08-12 |
| Heteroaryl carboxamides App 20080009624 - Hendrix; Martin ; et al. | 2008-01-10 |
| Heteroaryl carboxylic acid amides Grant 7,256,288 - Hendrix , et al. August 14, 2 | 2007-08-14 |
| 2,5-disubstituted pyrimidine derivatives Grant 7,091,198 - Feurer , et al. August 15, 2 | 2006-08-15 |
| 2,5-disubstituted Pyrimidine Derivatives App 20060167016 - Feurer; Achim ; et al. | 2006-07-27 |
| Morpoline-bridged indazole derivatives App 20060128700 - Feurer; Achim ; et al. | 2006-06-15 |
| Selective PDE 2 inhibitors as pharmaceuticals for improving perception Grant 7,022,709 - Boss , et al. April 4, 2 | 2006-04-04 |
| Substituted imidazotriazinones Grant 6,998,402 - Niewohner, legal representative , et al. Februar | 2006-02-14 |
| 4-amino-substituted pyrimidine derivatives App 20060014951 - Feurer; Achim ; et al. | 2006-01-19 |
| Heteroaryl carboxylic acid amides App 20050209236 - Hendrix, Martin ; et al. | 2005-09-22 |
| Substituted .alpha., .beta.-anellated butyrolactones Grant 6,723,718 - Stolle , et al. April 20, 2 | 2004-04-20 |
| Substituted alpha, beta-anellated butyrolactones App 20030158424 - Stolle, Andreas ; et al. | 2003-08-21 |
| Substituted imidazotriazinones App 20020198377 - Niewohner, Ulrich ; et al. | 2002-12-26 |
| Selective PDE 2 inhibitors as pharmaceuticals for improving perception App 20020132754 - Boss, Frank-Gerhard ; et al. | 2002-09-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 